Pharmaceutical composition for preventing or treating nail and skin tinea

Abstract

Disclosed is a pharmaceutical composition for preventing or treating nail and skin tinea, wherein the pharmaceutical composition for preventing or treating nail and skin tinea includes: an antifungal agent; a crystal growth inhibitor; and a keratin affinity inhibitor, and wherein the composition is a pharmaceutical composition which, as a topical preparation containing the antifungal agent, inhibits crystal growth during storage, prevents crystal precipitation after application, inhibits keratin affinity, and thereby has improved skin and nail permeability and antimicrobial power. The composition may comprise the antifungal agent as an active ingredient, and the crystal growth inhibitor, the keratin affinity inhibitor, a chelating agent, and additives (e.g., a vehicle, an antioxidant, or a pH adjuster) as auxiliary ingredients.

Dependencies are inferred from the claim text.